Adel Mekhail sold $743k of PBH
EVP, Marketing & Sales at Prestige Consumer Healthcare Inc.. 9,063 shares at an average of $82.00, traded Nov 12, 2024, filed Nov 14, 2024.
Score components
- +15RoleOfficer
- +21Trade size$743k at market
- +10Share of holdings soldSold 33% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -0.6%, 3m +3.5%, 6m +5.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-24-119387, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 12, 2024 | MOption exercise Common Stock, par value $0.01 per share | +5,565 | $44.33 | $247k | 27,428 | Nov 14, 2024 |
| Nov 12, 2024 | SOpen-market sale Common Stock, par value $0.01 per share | -9,063 | $82.00 | $743k | 18,365 | Nov 14, 2024 |
| Nov 12, 2024 | MOption exercise Employee Stock Options (rights to buy)derivative | -5,565 | $0.00 | $0 | 5,400 | Nov 14, 2024 |
Related signals
Other insiders at Prestige Consumer Healthcare Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | PBHsell Prestige Consumer Healthcare Inc. | Jeffrey Zerillo Senior VP Operations | $66k 1,000 shares | -2% | |
| 10Weak | Prestige Consumer Healthcare Inc. | Jeffrey Zerillo Senior VP Operations | $60k 1,000 shares | -2% | |
| 35Weak | Prestige Consumer Healthcare Inc. | John E Byom director | $178k 3,000 shares | -5% | |
| 6Weak | Prestige Consumer Healthcare Inc. | Mary Beth Fritz SVP Quality & Regulatory | $151k 1,678 shares | -9% | |
| 9Weak | Prestige Consumer Healthcare Inc. | Mary Beth Fritz SVP Quality & Regulatory | $538k 6,297 shares | -25% | |
| 49Moderate | Prestige Consumer Healthcare Inc. | Ronald M. Lombardi Chief Executive Officer | $898k 10,875 shares | -3% | |
| 55Moderate | Prestige Consumer Healthcare Inc. | Ronald M. Lombardi Chief Executive Officer | $6.8M 82,237 shares | -22% | |
| 47Moderate | Prestige Consumer Healthcare Inc. | Mary Beth Fritz SVP Quality & Regulatory | $810k 9,885 shares | -39% | |
| 61Notable | Prestige Consumer Healthcare Inc. | William P'Pool See Remarks | $736k 8,987 shares | -31% | |
| 57Moderate | Prestige Consumer Healthcare Inc. | Christine Sacco Chief Financial Officer | $2.0M 24,686 shares | -45% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.